DocGo Inc. (NASDAQ:DCGO) Receives $2.38 Consensus Price Target from Analysts

DocGo Inc. (NASDAQ:DCGOGet Free Report) has been assigned a consensus recommendation of “Hold” from the six analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $2.3750.

DCGO has been the topic of a number of analyst reports. Canaccord Genuity Group dropped their price objective on shares of DocGo from $1.50 to $1.00 and set a “hold” rating on the stock in a report on Wednesday, March 25th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a report on Thursday, June 18th. Needham & Company LLC restated a “buy” rating and set a $3.00 price objective on shares of DocGo in a research note on Tuesday, March 17th. Stifel Nicolaus cut their price objective on shares of DocGo from $4.00 to $2.50 and set a “buy” rating on the stock in a research note on Tuesday, March 17th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of DocGo in a research report on Monday, May 11th.

Check Out Our Latest Report on DocGo

DocGo Stock Performance

Shares of NASDAQ:DCGO opened at $0.50 on Thursday. The stock has a market capitalization of $49.82 million, a price-to-earnings ratio of -0.26 and a beta of 1.00. DocGo has a 1-year low of $0.49 and a 1-year high of $1.78. The company’s fifty day moving average is $0.61 and its two-hundred day moving average is $0.71.

DocGo (NASDAQ:DCGOGet Free Report) last issued its earnings results on Monday, May 11th. The company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.10). DocGo had a negative return on equity of 44.09% and a negative net margin of 62.23%.The business had revenue of $75.55 million for the quarter, compared to analyst estimates of $72.48 million. Sell-side analysts expect that DocGo will post -0.12 EPS for the current fiscal year.

Hedge Funds Weigh In On DocGo

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Geode Capital Management LLC grew its position in DocGo by 3.4% in the 4th quarter. Geode Capital Management LLC now owns 2,259,901 shares of the company’s stock valued at $1,984,000 after buying an additional 73,900 shares in the last quarter. State Street Corp grew its position in DocGo by 2.0% in the 4th quarter. State Street Corp now owns 1,969,603 shares of the company’s stock valued at $1,729,000 after buying an additional 39,125 shares in the last quarter. Renaissance Technologies LLC grew its position in DocGo by 167.1% in the 1st quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock valued at $950,000 after buying an additional 944,826 shares in the last quarter. Isthmus Partners LLC grew its position in DocGo by 14.0% in the 1st quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock valued at $637,000 after buying an additional 124,211 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its position in DocGo by 205.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 805,427 shares of the company’s stock valued at $707,000 after buying an additional 541,670 shares in the last quarter. Institutional investors own 56.44% of the company’s stock.

About DocGo

(Get Free Report)

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.

Read More

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.